Rani Therapeutics rallies $39 mln Series D

San Jose, California-based Rani Therapeutics, which helps convert injectable drugs into pills, has raised $39 million in Series D funding, according to a source familiar with the fundraising. The investors in this round included GV.

12 September 2017•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail